SURIN RODINO: Open Payments
NPI 1215280946 · SPRINGFIELD, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$342 in 16 payments from 8 companies in 2025. Trend: 2023 $47 · 2024 $280 · 2025 $342
Food & beverage: $342
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $96 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $71 |
| AstraZeneca Pharmaceuticals LP | 2 | $52 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $34 |
| Lilly USA, LLC | 2 | $31 |
| PFIZER INC. | 1 | $22 |
| Exact Sciences Corporation | 1 | $19 |
| Amgen Inc. | 1 | $17 |
Products named: JARDIANCE, Ozempic, Kerendia, MOUNJARO, AIRSUPRA, PAXLOVID, BREZTRI, Rybelsus.
Industry payments across VA — which companies pay providers there.
